Previous close | 146.05 |
Open | 148.32 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 142.65 - 150.78 |
52-week range | 118.16 - 152.06 |
Volume | |
Avg. volume | 3,977 |
Market cap | 232.269B |
Beta (5Y monthly) | 0.19 |
PE ratio (TTM) | 35.83 |
EPS (TTM) | 4.05 |
Earnings date | N/A |
Forward dividend & yield | 2.86 (1.97%) |
Ex-dividend date | 22 Feb 2024 |
1y target est | N/A |
As you might know, AstraZeneca PLC ( LON:AZN ) just kicked off its latest quarterly results with some very strong...
Merck (MRK), Sanofi (SNY), Novartis (NVS) and AstraZeneca (AZN) announce their first-quarter results.
Fusion (FUSN) is expected to provide updates regarding the developmental program of its lead candidate, FPI-2265, for prostate cancer in the first-quarter earnings release.